Loading clinical trials...
Loading clinical trials...
Phase I Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer
Conditions
Interventions
18F-FDG (Fluorodeoxyglucose) PET
Carboplatin
+1 more
Locations
1
United States
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
April 1, 2014
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
January 8, 2026
NCT04674267
NCT07217704
NCT07464470
NCT07132918
NCT07367516
NCT06346080
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions